Doubling back on centromere 17 in early breast cancer

Lancet Oncol. 2010 Mar;11(3):216-7. doi: 10.1016/S1470-2045(10)70020-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / pharmacology*
  • Antigens, Neoplasm / genetics*
  • Biomarkers, Pharmacological*
  • Breast Neoplasms / drug therapy*
  • Centromere
  • DNA Topoisomerases, Type II / genetics*
  • DNA-Binding Proteins / genetics*
  • Epirubicin / administration & dosage
  • Epirubicin / pharmacology*
  • Female
  • Gene Amplification
  • Genes, erbB-2 / genetics*
  • Humans

Substances

  • Antibiotics, Antineoplastic
  • Antigens, Neoplasm
  • Biomarkers, Pharmacological
  • DNA-Binding Proteins
  • Epirubicin
  • DNA Topoisomerases, Type II